Nuvation Bio Inc.

8-K Took on a direct financial obligation; Other events Jul 6, 2026 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Other events Jun 30, 2026 8-K Shareholder vote results May 27, 2026 8-K Results of operations (earnings release) May 4, 2026 10-Q Quarter ended 2026-03-31 May 4, 2026 10-K Fiscal year ended 2025-12-31 Mar 2, 2026 8-K Results of operations (earnings release) Mar 2, 2026 8-K Entered a material agreement; Results of operations (earnings release); Regulation FD disclosure Jan 12, 2026 8-K Regulation FD disclosure; Other events Nov 26, 2025 8-K Regulation FD disclosure; Other events Nov 17, 2025 10-Q Quarter ended 2025-09-30 Nov 3, 2025 8-K Results of operations (earnings release) Nov 3, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Regulation FD disclosure; Other events Jun 11, 2025 8-K Shareholder vote results May 23, 2025 10-Q Quarter ended 2025-03-31 May 7, 2025 8-K Results of operations (earnings release) May 7, 2025 8-K Entered a material agreement Mar 25, 2025 10-K Fiscal year ended 2024-12-31 Mar 6, 2025 8-K Results of operations (earnings release) Mar 6, 2025 8-K Entered a material agreement Mar 5, 2025 8-K Entered a material agreement; Took on a direct financial obligation Mar 4, 2025 8-K Director or officer change Feb 12, 2025 8-K Results of operations (earnings release) Nov 6, 2024 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Director or officer change Oct 7, 2024 8-K Shareholder vote results; Other events Sep 5, 2024 10-Q Quarter ended 2024-06-30 Aug 5, 2024 8-K Results of operations (earnings release) Aug 5, 2024 8-K/A Other events Jun 20, 2024 10-Q Quarter ended 2024-03-31 May 14, 2024 8-K Results of operations (earnings release) May 14, 2024 10-K/A Fiscal year ended 2023-12-31 Apr 26, 2024 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Modified rights of security holders; Director or officer change; Amended charter or bylaws Apr 10, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Mar 25, 2024 10-K Fiscal year ended 2023-12-31 Feb 29, 2024 8-K Results of operations (earnings release) Feb 29, 2024 8-K Director or officer change Jan 8, 2024 8-K Director or officer change Dec 14, 2023